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Cytochrome c and dATP-Dependent
Formation of Apaf-1/Caspase-9 Complex
Initiates an Apoptotic Protease Cascade
Horvitz, 1992; Yuan et al., 1993; Fernandes-Alnemri et
al., 1994; Nicholson et al., 1995; Tewari et al., 1995; Xue
et al., 1996; Zou et al., 1997).
ced-4 has been determined genetically to function
downstream of ced-9 but upstream of ced-3 (Shaham
Peng Li,*³ Deepak Nijhawan,*³ Imawati Budihardjo,*
Srinivasa M. Srinivasula,² Manzoor Ahmad,²
Emad S. Alnemri,² and Xiaodong Wang*§
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and Horvitz, 1996a, 1996b). Likewise, Apaf-1 functionsUniversity of Texas Southwestern Medical Center
downstream of bcl-2 but upstream of caspase-3 (Zouat Dallas
et al., 1997). Bcl-2 may function upstream of Apaf-1 byDallas, Texas 75235
regulating the release of cytochrome c from mitochon-²Center for Apoptosis Research
dria. Cytochrome c is a required cofactor for Apaf-1and the Department of Microbiology and Immunology
function (Liu et al., 1996b; Zou et al., 1997). ConsistentKimmel Cancer Institute
with this hypothesis, overexpression of bcl-2, or its closeThomas Jefferson University
family member bcl-Xl, blocks the release of cytochromePhiladelphia, Pennsylvania 19107
c from mitochondria, which otherwise occurs when cells
are signaled to undergo apoptosis (Kharbanda et al.,
1997; Kim et al., 1997; Kluck et al., 1997; Yang et al.,Summary
1997). In addition, the bcl-2 family of proteins might also
directly interact with Apaf-1 in a fashion similar to theWe report here the purification of the third protein
interaction between CED-4 and CED-9 (Chinnaiyan etfactor, Apaf-3, that participates in caspase-3 activa-
al., 1997; Seshagiri and Miller, 1997; Spector et al., 1997;tion in vitro. Apaf-3 was identified as a member of the
Wu et al., 1997).caspase family, caspase-9. Caspase-9 and Apaf-1
Various stimuli of apoptosis lead to the activation of abind to each other via their respective NH2-terminal family of cysteine proteases with specificity for asparticCED-3 homologous domains in the presence of cyto-
acid residues, referred to as caspases (Alnemri et al.,chrome c and dATP, an event that leads to caspase-9
1996). The activated caspases cleave a variety of targetactivation. Activated caspase-9 in turn cleaves and
proteins, thereby disabling important cellular processesactivates caspase-3. Depletion of caspase-9 from
and breaking down structural components of the cellS-100 extracts diminishedcaspase-3 activation. Muta-
(Nicholson and Thornberry, 1997). The targets of suchtion of the active site of caspase-9 attenuated the
cleavage events include poly(ADP-ribose) polymeraseactivation of caspase-3 and cellular apoptotic re-
(Nicholson et al., 1995; Tewari et al., 1995), sterol regula-
sponse in vivo, indicating that caspase-9 is the most
tory element binding proteins (Wang et al., 1996), retino-
upstream member of the apoptotic protease cascade
blastoma (RB) protein (An et al., 1996; Janicke et al.,
that is triggered by cytochrome c and dATP.
1996), nuclear lamins (Lazebnik et al., 1995; Orth et al.,
1996; Takahashi et al., 1996), DNA-dependent protein
Introduction kinase (Casciola-Rosen et al., 1996; Song et al., 1996),
U1 70-K protein (Caciola-Rosen et al. 1996), and the
Apoptosis is a morphologically and biochemically dis- large subunit of the DNA replication complex C (Ubeda
tinct form of cell death carried out by a genetically deter- and Habener, 1997). In addition, activated caspases lead
mined cell suicide program (Kerr et al., 1972; reviewed to cleavage of the 45 kDa subunit of DNA fragmentation
by Horvitz et al., 1994; Jacobson et al., 1997). Several factor (DFF-45). This cleavage activates a pathway lead-
apoptosis-regulating genes identified in Caenorhabditis ing to fragmentation of genomic DNA into nucleosomal
elegans have counterparts in humans, demonstrating fragments, a hallmark of apoptosis (Liu et al., 1997).
that the basic mechanism of apoptosis is evolutionarily Caspase-3 is activated by two sequential proteolytic
conserved (Vaux, 1997). events that cleave the 32 kDa precursor at aspartic acid
Three genes, ced-3, ced-4, and ced-9, encode the residues to generate an active heterodimer of 20 kDa
general apoptotic program in C. elegans (Horvitz et al., and 12 kDa subunits (Nicholson et al., 1995). The activa-
1994). ced-9 negatively regulates apoptosis while ced-4 tion might be autocatalytic, or it might occur via a cas-
and ced-3 are required to execute the apoptotic pro- pase cascade, similar to the serine protease cascade
gram (Yuan and Horvitz, 1990; Hengartner et al., 1992). in the blood clotting process. Such a cascade might
The bcl-2 family of proteins are mammalian relatives of amplify apoptotic signals leading to fast and irreversible
CED-9 (Vaux et al., 1992; Hengartner and Horvitz, 1994). apoptosis. The active caspases are promiscuous in
Bcl-2 is an integral membrane protein located mainly cleaving other caspases, making it difficult to identify
on the outer membrane of mitochondria (Monaghan et the initial triggering event in caspase activation (Tewari
al., 1992; Krajewski et al., 1993; de Jong et al., 1994). et al., 1995; Liu et al., 1996a; Muzio et al., 1996; Sriniva-
CED-4 is homologous to the recently identified human sula et al., 1996a; Wang et al., 1996).
protein, Apaf-1, which participates in the activation of We have recently established an in vitro system in
the mammalian CED-3 homolog, caspase-3 (Yuan and which caspase-3 is activated by the addition of dATP
to cytosol from normally growing cells (Liu et al., 1996b).
This system enabled us to study the triggering events³These authors contributed equally to this work.
§To whom correspondence should be addressed. in caspase-3 activation. Fractionation of HeLa cytosol
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Figure 1. Glycerol Gradient Purification of Apaf-3 and Its Identification as Caspase-9/Mch6/ICE-LAP6
The Apaf-3 activity was purified through the glycerol gradient step as described in Experimental Procedures.
(A) Aliquots of 1 ml of glycerol gradient fractions were incubated with aliquots of 4 ml of Apaf-1 fraction bound to hydroxylapatide column
(Zou et al., 1997), 1 ml (0.2 mg) of cytochrome c, 3 ml of in vitro±translated, 35S-labeled, and affinity-purified Caspase-3, and 1 mM dATP at
308C for 1 hr in a final volume of 20 ml of buffer A. After 1 hr at 308C, the samples were subjected to 15% SDS-PAGE and transferred to a
nitrocellulose filter. The filter was exposed to a phosphorimaging plate for 16 hr at room temperature.
(B) Aliquots (30 ml) of the indicated glycerol gradient fractions were subjected to 8% SDS-PAGE, and the gel was subsequently stained with
silver using a Silver Stain Plus kit from Bio-Rad.
(C) The Apaf-3 peak fractions from the Mono Q column as described in the Experimental Procedures were subjected to 8% SDS-PAGE and
electroblotted onto a PVDF membrane. The 46 kDa polypeptide band correlated with Apaf-3 activity was excised from the membrane and
subjected to trypsin digestion. The resulting peptides were separated by a reverse-phase HPLC column, and the amino acids sequences of
two individual peptides (underlined) were determined by Edman degradation in an Applied Biosystems sequencer. The amino acid sequence
of caspase-9 was as reported in Srinivasula et al. (1996a). The conserved active site pentapeptide QACGG is boxed. The asterisk denotes
the amino acid residue after which the cleavage occurs during caspase-9 activation (Srinivasula et al., 1996a).
revealed that three protein factors, designated apop- caspase-9 in turn cleaves and activates caspase-3. An
active site mutant of caspase-9 blocks caspase-3 acti-totic protease activating factors (Apafs), are necessary
and sufficient to reconstitute dATP-dependent caspase-3 vation and cellular apoptosis in vivo. These data demon-
strate an orderly activation of the caspase cascade dur-activation (Zou et al., 1997). The NH2-terminal region of
Apaf-1 shares sequence similarity with the prodomain ing apoptosis.
of CED-3 and other caspases with long prodomains,
including caspase-1/ICE (Thornberry et al., 1992), cas- Results
pase-2/ICH-1 (Wang et al., 1994), and caspase-9/Mch6/
ICE-LAP6 (Duan et al., 1996; Srinivasula et al., 1996a). Purification of Apaf-3 and Its Identification
as Caspase-9This domain may serve as a caspase recruitment domain
(CARD) by binding to caspases that have similar CARDs Caspase-3 activation was assayed by incubating in
vitro±translated, 35S-labeled, and affinity-purified cas-at their NH2 termini (Hofmann et al., 1997; Zou et al.,
1997). The CARD of Apaf-1 is followed by a stretch of pase-3 with HeLa S-100 cytosolic fraction. Caspase-3
activation was initiated by the addition of dATP. The320 amino acids that are homologous to CED-4. The
C-terminal part of Apaf-1 is composed of 12 putative activated 20 kDa and 12 kDa fragments were separated
from the 32 kDa precursor by SDS-PAGE (polyacrylamideWD40 repeats, a protein motif believed to mediate pro-
tein±protein interactions (Neer et al., 1994; Wall et al., gel electrophoresis) and visualized by phosphorimaging
(Liu et al., 1996b; Zou et al., 1997).1995; Sondek et al., 1997). Apaf-2 has been identified
as cytochrome c, which was released to the cytosol The separation of Apaf-1, -2, and 23 was initiated by
applying HeLa cell S-100 to an SP-Sepharose column.during homogenization (Liu et al., 1996b).
In the current studies, we have purified the third apop- Cytochrome c (Apaf-2) bound to the column while Apaf-1
and Apaf-3 flowed through it. Apaf-1 and Apaf-3 weretotic protease activating factor, Apaf-3, and we have
used it to reconstitute the caspase-3 activation reaction further separated on a hydroxylapatite column, which
bound Apaf-1 but not Apaf-3. Apaf-3 was furtherpurifiedusing purified components. Protein sequencing and im-
munoblot analysis revealed that Apaf-3 is identical to by the following six additional steps: Q-Sepharose ion-
exchange chromatography, phenyl-sepharose hydro-caspase-9/Mch6/ICE-LAP6 (Alnemri et al., 1996; Duan
et al., 1996; Srinivasula et al.,1996a). Caspase-9 binds to phobic-interaction chromatography, heparin-agarose ion-
exchange chromatography, Superdex 200 gel filtrationApaf-1 in a cytochrome c± and dATP-dependent fashion
and becomes activated under such condition. Activated chromatography, Mono Q ion-exchange chromatography,
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98±112 and 325±337, respectively, of human caspase-
9/MCH6/ICE-LAP6 (Figure 1C, underlined).
Reconsititution of Caspase-3 Activation
with Purified Components
Figure 2A shows the reconstitution of the caspase-3
activation reaction using three purified proteins: Apaf-1,
cytochrome c, and Apaf-3. No single component nor any
combination of two was sufficient to activate caspase-3
(lanes 1±6). All three proteins plus dATP were required
to cleave caspase-3 (lane 7).
Using a polyclonal antibody generated against a re-
combinant caspase-9 fusion protein, we examined the
cleavage of caspase-9 during the caspase-3 activation
reaction by immunoblot analysis (Figure 2B). Apaf-3 was
recognized by the anti-caspase-9 antibody, confirming
that Apaf-3 is caspase-9 (lanes 3 and 5±8). Caspase-9
was activated in the presence of Apaf-1, cytochrome c,
and dATP regardless of whether caspase-3 was present
(lanes 7 and 8), indicating that caspase-9 activation is
independent of caspase-3 activity.
Figure 2. Reconstitution of Caspase-3 Activation with Purified Caspase-9 Is Required for Caspase-3 Activation
Components
To further demonstrate that caspase-9 is upstream of
Aliquots (2 ml) of in vitro±translated, 35S-labeled, and affinity±purified
caspase-3, we immunodepleted caspase-9 from thecaspase-3 were incubated at 308C for 1 hr with aliquots of 2 ml
HeLa cell S-100 fraction using the antibody against cas-Apaf-1 purified through the Mono Q column step as described in
pase-9. As shown in Figure 3, S-100 depleted of eitherZou et al. (1997) (lanes 1, 4, 5, and 7), or 1 ml (0.3 mg) cytochrome
c (lanes 2, 4, 6, and 7), or 2 ml of purified Apaf-3 (12.5 ng) (lanes 3 caspase-9 or cytochrome c failed to activate caspase-3
and 5±7) in a final volume of 20 ml buffer A supplemented with 1 (lanes 3, 4, 7, and 8). Caspase-3 was not depleted by
mM dATP and 1 mM MgCl2. In lane 8, Apaf-1, cytochrome c and the antibodies against caspase-9 or cytochrome c since
Apaf-3 were incubated as described above in the absence of in
the caspase-3 precursor was present at approximatelyvitro-translated 35S-labeled caspase-3. After incubation, samples
the same level in all reactions (Figure 3B). Addition of puri-were subjected to 15% SDS-PAGE and transferred to a nitrocellu-
fied Apaf-3 or cytochrome c to extracts depleted of thelose filter.
(A) The filter was exposed to a phosphorimaging plate for 2 hr at respective proteins restored the cleavage of caspase-3
room temperature. (lanes 5, 6, 9, and 10). The endogenous caspase-3 pre-
(B) The same filter was probed with a polyclonal anti-caspase-9 cursor present in these extracts was cleaved in the same
antibody generated as described in the Experimental Procedures.
fashion as the 35S labeled caspase-3 (Figure 3B).The antigen/antibody complex was visualized by an ECL method
as described in the Experimental Procedure. The filter was exposed
to a Kodak X-Omat AR X-ray film for 10 s. Activated Caspase-9 Cleaves Caspase-3
The above data indicate that caspase-9 is the upstream
caspase in a protease cascade that activates caspase-3.
To demonstrate that active caspase-9 cleaves caspase-3,and finally, glycerol gradient centrifugation. The results
we generated recombinant active caspase-9 enzyme byof the glycerol gradient are shown in Figure 1. After
overexpressing it in bacteria.centrifugation, the fractions were collected from bottom
As shown in Figure 4, activated caspase-9 cleavesto top and assayed for Apaf-3 activity by incubating
and activates caspase-3 in as early as 15 min. Thiseach fraction with partially purified Apaf-1 (hydrox-
implies that, once caspase-9 becomes activated, it willylapatite bound fraction), cytochrome c, and 35S-labeled
initiate a protease cascade leading to the rapid activa-caspase-3 in the presence of dATP. Apaf-3 activity ap-
tion of caspsase-3, a major caspase activity in cellspeared in fractions 6±8 with a peak at fraction 7 (Figure
undergoing apoptosis (Faleiro et al., 1997; Martins et1A). The same fractions were subjected to SDS-PAGE
al., 1997; Takahashi et al., 1997). The enzymatic activityfollowed by silver stain (Figure 1B). A single polypeptide
of caspase-9 can be inhibited by zVAD-fmk, a generalband migrating just above the 45 kDa molecular weight
caspase inhibitor that blocks cellular apoptotic re-marker coeluted with the Apaf-3 activity. The NH2 termi-
sponse (data not shown).nus of this protein band was blocked to Edmandegrada-
tion. To obtain protein sequence, the polypeptide band
was blotted onto a PVDF membrane and subjected to Evidence that Hydrolysis of dATP or ATP
tryptic digestion. The resulting tryptic peptides were Is Required for Caspase-9 Activation
separated by a reverse-phase HPLC column, and the Using only purified components, we reconstituted the
sequences of two peptides were determined by Edman caspase-3 activation reaction in the presence of varying
degradation. A database search revealed that the two concentrations of either dATP or ATP (Figure 5). Cas-
peptide sequences, LSKPTLENLTPVVLR and TFDQLD pase-9 and caspase-3 were both activated in the pres-
ence of 1 mM dATP (lane 3, panels A and B). SimilarISSLPTP, matched perfectly with amino acid residues
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Figure 3. Caspase-9 and Cytochrome c Are
Required for Caspase-3 Activation
Depletion of caspase-9 from HeLa cell S-100
was performed as described in the Experi-
mental Procedures. Depletion of cytochrome
c was as described in Liu et al. (1996b).
(A) Aliquots (50 mg) of HeLa cell S-100 (lanes
1 and 2), or Hela S-100 immunodepleted of
caspase-9 (lanes 3±6),or Hela S-100 immuno-
depleted of cytochrome c (lanes 7±10) were
incubated with aliquots (3 ml) of in vitro±
translated, 35S-labeled caspase-3 in the ab-
sence (lanes 1, 3, 5, 7, and 9) or presence
(lanes 2, 4, 6, 8, and 10) of 1 mM dATP in a
final volume of 20 ml of buffer A. Aliquots of
6 ml of Apaf-3 (37.5 ng) purified to the Mono
Q step (lanes 5 and 6), or 0.2 mg purified cy-
tochrome c (lanes 9 and 10) were supple-
mented to the indicated reactions. After incu-
bating at 308C for 1 hr, the samples were
subjected to 15% SDS-PAGE, and the gel
was subsequently transferred to a nitrocellu-
lose filter. The filter was exposed to film for
3 days at 2808C.
(B) Same reactions were performed as in (A)
except the in vitro±translated, 35S-labeled
caspase-3 was omitted. The samples were
then subjected to 15% SDS-PAGE followed
by electroblotting to a nitrocellulose filter. The
filter was probed with 25 mg of a monoclonal
antibody to caspase-3 (Transduction Labora-
tories). The antigen/antibody complexes were
visualized by an ECL method as described in
Experimental Procedures. The filter was ex-
posed to Kodak X-OMAT X-ray film for 10 min.
activation occurred in the presence of ATP, but a much by coimmunoprecipitation using the antibody against
caspase-9. The precipitates were analyzed by immu-higher concentration of ATP (1 mM) was required (lane
7). This result is consistent with our previous observation noblotting with an antibody against Apaf-1 (Zou et al.,
1997). As shown in Figure 6A, the anti-caspase-9 anti-that dATP is the preferred nucleotide for activation (Liu
et al., 1996b). Neither caspase-9 nor caspase-3 was body precipitated Apaf-1 in the presence of cytochrome
c, dATP and Apaf-3 (lane 10). Preimmune serum fromcleaved in the presence of the nonhydrolyzable ATP
analogs, AMP-PNP or ATP-g-S, suggesting that hydroly- the same animal did not precipitate Apaf-1 (lane 9).
Omission of dATP (lanes 7±8), cytochrome c (lanes 3±6),sis is required for the reaction (lanes 8±13). dADP, a
nucleotide that substitutes for dATP in the crude system Apaf-3 (lanes 11±12), or Apaf-1 (lanes 1±2) obliterated
coimmunoprecipitation of Apaf-1.(Liu et al., 1996b), did not function in the purified system
(data not shown). We suggest that dADP was converted To further demonstrate that the interaction of cas-
pase-9 with Apaf-1 requires cytochrome c and dATP, weto dATP in the crude system.
performed the same coimmunoprecipitation experiment
with HeLa S-100 immunodepleted of cytochrome c (Fig-Apaf-1 and Caspase-9 Form a Complex in
the Presence of dATP and Cytochrome c ure 6B). This extract possessed no caspase-3 activating
activity unless purified cytochrome c was added to theTo further explore the mechanism of caspase-9 activa-
tion, we studied the interaction of caspase-9 with Apaf-1 reaction (Figure 3, lanes 7±10 ). Apaf-1 was coimmuno-
precipitated with caspase-9 in this extract only when
both cytochrome c and dATP were added (lane 8). Pre-
immune serum did not precipitate Apaf-1 (lane 7).
Caspase-9 Binds to Apaf-1 through
Interaction of CARDs
Several caspases, including caspase-9, have long pro-
domains at their NH2 termini. This domain has been
Figure 4. Caspase-9-Mediated Cleavage of Caspase-3 proposed to function as a CARD, allowing proteins with
Active caspase-9 was prepared as described in the Experimental such domains to interact with each other (Hofmann et
Procedures. Aliquots (10 ng) of active caspase-9 were incubated al., 1997). Although Apaf-1 is not a caspase, its NH2-with aliquots (0.5 ml) of in vitro±translated, 35S-labeled, and affinity-
terminal region containsa CARD, suggesting that Apaf-1purified caspase-3 precursor for the indicated times at 378C. The
may recruit caspase-9 through their respective CARDssamples were subsequently subjected to 15% SDS-PAGE and ex-
posed to X-ray film for 12 hr at room temperature. (Zou et al., 1997). To test this possibility directly, we
Initiation of an Apoptotic Protease Cascade
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Figure 5. Titration of dATP, ATP, and Nonhy-
drolyzable ATP Analogs in the Activation of
Caspase-3 and Caspase-9
Aliquots (2 ml) of Apaf-1 purified through the
Mono Q column step as described in Zou et
al. (1997) were incubated at 308C for 1 hr with
aliquots of 2 ml of purified Apaf-3 (12.5 ng),
1 ml (0.3 mg) cytochrome c, and 2 ml of in
vitro±translated, 35S-labeled, and affinity-
purified caspase-3 in a final volume of 20 ml
of buffer A in the absence of nucleotides (lane
1), or in the presence of increasing concentra-
tions of dATP (lanes 2, 3, and 4), ATP (lanes
5, 6, and 7), AMP-PNP (lanes 8, 9, and 10),
or ATP-g-S ( lanes 11, 12, and 13). Samples
weresubjected to 15% SDS-PAGE and trans-
ferred to a nitrocellulose filter.
(A) The filter was exposed to a phosphorim-
aging plate for 2 hr at room temperature.
(B) The same filter was probed with a poly-
clonal anti-caspase-9 antibody generated as
described in the Experimental Procedures.
The antigen/antibody complex was visualized
by an ECL method as described in the Experi-
mental Procedure. The filter was exposed to
a Kodak X-Omat AR X-ray film for 10 s.
expressed the first 97 amino acids of Apaf-1 fused to a Bax is a member of the bcl-2 family that opposes the
action of bcl-2 and accelerates cell death when overex-GST protein and studied its interaction with caspase-9.
As shown in Figure 7, wild-type caspase-9 translated pressed in mammalian cells (Oltvai et al., 1993). Overex-
pression of Bax in human MCF-7 cells elicited apoptosisin vitro bound to the CARD of Apaf-1. The active site
mutation, cysteine 287 to alanine, also bound to this in nearly 90%of the transfected cells (Figure 8). Cotrans-
fection with the active site mutant of caspase-9 reducedfusion protein. Caspase-9 without its prodomain no
longer bound. Caspase-3, which does not have a long the percentage of cells undergoing apoptosis to about
20%, which is near the background level.prodomain, did not bind to the CARD of Apaf-1 either.
GST alone did not bind caspase-9. In contrast to the To confirm that the active site mutant of caspase-9
(C287A) blocks apoptosis by inhibiting caspase-3 acti-results with full-length Apaf-1, we found that the CARD-
GST fusion protein bound caspase-9 in the absence of vation, we analyzed caspase-3 in human embryonic kid-
ney cells (293 cells) that were transfected with Bax, orcytochrome c and dATP (data not shown). These data
suggest that, within the context of full-length Apaf-1, Bax plus the mutant caspase-9 (C287A). As shown in
Figure 8B, activation of caspase-3 was detected in cellsthe CARD is not accessible for caspase-9 binding. Cyto-
chrome c and dATP may induce a conformational change that were overexpressing Bax (lane 2). The activation of
caspase-3 was decreased to about 50% when an equalin Apaf-1 that exposes its CARD.
amount of mutant caspase-9 was coexpressed with
Bax, and the activation of caspase-3 was completelyActive Site Mutation of Caspase-9
blocked when a 4-fold excess amount of mutant cas-Blocks Caspase-3 Activation
pase-9 was used (lanes 3±4).and Apoptosis In Vivo
Inasmuch as the active site mutant version of caspase-9
binds to Apaf-1, we designed experiments to determine
whether this mutant protein exerts a dominant-negative Discussion
influence on activation of caspase-3 and cellular apop-
tosis response in vivo. In the current report, we present experimental data that
suggest a mechanism for the activation of caspase-3/When human breast carcinoma MCF-7 cells were tran-
siently transfected with an expression vector, about 17% CPP32, a major caspase activity in cells undergoing
apoptosis (Faleiro et al., 1997; Martins et al., 1997; Taka-of the cells showed spontaneous apoptosis (Figure 8A).
When the vector encoded full-length Apaf-1 or wild-type hashi et al., 1997). The model, shown in Figure 9, indi-
cates that caspase-3 activation begins when caspase-9caspase-9, there was a slight increase to 26% and 29%,
respectively. When Apaf-1 and wild-type caspase-9 were binds to Apaf-1 in a reaction triggered by cytochrome
c and dATP. Complex formation between Apaf-1 andcoexpressed, almost 60% of the cells underwent
apoptosis. When the active site mutant of caspase-9 caspase-9 is mediated by the CARD on the two proteins.
Binding leads to the cleavage of caspase-9, converting(C287A) was coexpressed with Apaf-1, the number of
cells undergoing apoptosis decreased to about 10%. it to an active protease. Active caspase-9 then cleaves
Cell
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Figure 6. Formation of Apaf-1/Caspase-9
Complex
(A) Apaf-1 and Apaf-3 were seperated by a
hydroxyapatite column as described in Zou
et al. (1997) and used for the immunoprecipi-
tation experiment. Aliquots of 50 ml of the
Apaf-1 fraction, 100 ml of the Apaf-3 fraction,
0.5 ml (10 mg/ml) of purified cytochrome c,
and dATP to a final concentration of 1 mM
were added as indicated to a final volume of
500 ml of buffer A. 500 mg of BSA was also
added to all reactions to reduce nonspecific
binding to the beads. After incubating at 308C
for 20 min, aliquots (25 ml) of anti-caspase-9
antibody/protein A beads prepared as in Ex-
perimental Procedures were added to the re-
action. After incubation with rotation over-
night at 48C, the beads were centrifuged and
washed with 1 ml of buffer A three times. The
beads were then resuspended in 60 ml of 13
SDS loading buffer. After boiling for 5 min,
the beads were pelleted by centrifugation and
the supernatants were collected. Aliquots of
15 ml of resulting supernatants were sub-
jected to 8% SDS-PAGE followed by elec-
troblotting to a nitrocellulose filter. Purified
Apaf-1 (5 ng) was loaded on lane 13. The filter
was probed with the serum against Apaf-1
(1:2000 dilution) as described in Zou et al.
(1997). The antigen/antibody complexes were
visualized by an ECL method as described
in Experimental Procedures. The filter was
exposed to Kodak X-OMAT X-ray film for 1
min at room temparature. P, preimmune serum, I immune serum. (B) Aliquots of 120 ml (900 mg protein) of the Hela cell S-100 extract
immunodepleted of cytochrome c (see Figure 3) were incubated in the absence (lanes 1, 2, 5, and 6) or presence (lanes 3, 4, 7, and 8) of 1
mM dATP at 308C for 20 min in a final volume of 500 ml of buffer A. Purified cytochrome c (5 mg) was added to lanes 3, 4, 7, and 8. Purified
Apaf-1 (5 ng) was loaded on lane 9. After incubation, the samples were subjected to immunoprecipitation and Western blot analysis as
described in (A). The filter was exposed to Kodak X-OMAT film for 1 s (lanes 1±8) or 15 s (lane 9).
and activates caspase-3, thereby setting in motion the purified cytochrome c was added back (Figure 3). The
essential role of cytochrome c was furtherdemonstratedevents that lead to DNA fragmentation and cell death.
in the coimmunoprecipitation experiment. When cyto-
chrome c was depleted, caspase-9 failed to bind Apaf-1Role of Apaf-1
The current data suggest that Apaf-1 serves as a dock- even in the presence of dATP. The binding was restored
when purified cytochrome c was added(Figure 6). Theseing protein for caspase-9 and cytochrome c. Apaf-1 is
a 130 kDa protein that possesses three distinct domains data strongly support the suggestion that cytochrome
c initiates apoptosis by inducing the formation of the(Zou et al., 1997). The NH2-terminal 85 amino acids are
homologous to the CARD segment in the prodomain of Apaf-1/caspase-9 complex.
Holocytochrome c is normally present exclusively inseveral caspases, including CED-3, caspase-1, cas-
pase-2, and caspase-9 (Thornberry et al., 1992; Yuan et mitochondria. Apocytochrome c that is newly synthe-
sized in the cytosol cannot activate apoptosis (Yang etal., 1993; Wang et al., 1994; Duan et al., 1996; Srinivasula
et al., 1996a). CARDs have been proposed to mediate al., 1997). In response to a variety of apoptosis-inducing
agents, cytochrome c is released from mitochondria tothe recruitment of caspases (Hofmann et al., 1997). In-
deed, the CARD of Apaf-1 readily binds to caspase-9 the cytosol (Liu et al., 1996; Kharbanda et al., 1997; Kim
et al., 1997; Kluck et al., 1997; Yang et al., 1997). In cells(Figure 7). These data do not exclude the possibility that
caspase-9 interacts with other regions of Apaf-1 as well. overexpressing bcl-2, or its close family member bcl-xl,
the release of cytochrome c is blocked, aborting theApaf-1 binds caspase-9 only in the presence of cyto-
chrome c and dATP. This suggests that the CARD of apoptotic response (Kharbanda et al., 1997; Kim et al.,
1997; Kluck et al., 1997; Yang et al., 1997). CytochromeApaf-1 is normally not exposed when cytochrome c is
absent from the cytosol. c binds to Apaf-1 in the absence of dATP (Zou et al.,
1997), but this complex will not bind caspase-9 unless
dATP or ATP is present (Figure 6). It is likely that theRole of Cytochrome c
Cytochrome c is absolutely required in our in vitro sys- nucleotide induces a conformational change in the
Apaf-1/cytochrome c complex that exposes the CARDtem for the activation of caspase-3 and caspase-9.
When cytochrome c was depleted from HeLa cell S-100 domain of Apaf-1, allowing caspase-9 to bind. The pre-
cise region of Apaf-1 that binds cytochrome c has notextracts by a monoclonal antibody, the ability to activate
caspases was abolished. Activity was restored when yet been mapped.
Initiation of an Apoptotic Protease Cascade
485
Figure 7. Apaf-1 and Caspase-9 Interact via their CARDs
The CARD domain of Apaf-1 (residues 1±97) was subcloned into the
bacterial expression vector pGEX-5X-3 in-frame with an N-terminal
GST tag. GST and GST-APAF-1-CARD fusion protein were ex-
pressed in E. coli DH5a bacteria and then immobilized on glutathi-
one-Sepharose. Labeled interacting proteins were prepared as in
Figure 4, and aliquots of 1/10 of the input for binding assay were
subjected directly to SDS-PAGE and visualilzed by autoradiography.
Equal amounts of the indicated translation reactions were diluted Figure 8. Inhibition of Apoptosis and Caspase-3 Activation by an
to 150 ml with GST binding buffer (50 mM Tris-HCl [pH 7.6], 120 mM Active Site Mutant of Caspase-9
NaCl, and 0.5% Brij supplemented with protease inhibitors) and Human MCF-7 and 293 cells were transiently transfected with the
allowed to incubate with the immobilized GST or GST-Apaf-1(1±97) indicated plasmids as described in the Experimental Procedures.
at 48C for 2 hr with rotation. The beads were pelleted by centrifuga- (A) The graph shows the percentage of round blue apoptotic MCF-7
tion and washed four times with the same buffer and boiled for 3 min cells as a function of total blue cells under each condition.
in 13 SDS sample buffer. After a brief centrifugation, the resulting (B) Human embryonic kidney cells (293 cells) were transfected with
supernatants were subjected to a 10% SDS gel and visualized by the indicated amount of Bax in pCIneo vector together with the
autoradiography. indicated amount of plasmid containing C287A mutant caspase-9
as described in the Experimental Procedures. Cells were collected
30 hr after transfection, and the cell lysates were analyzed by West-
ern blot analysis using a polyclonal antibody against human cas-Role of dATP/ATP pase-3.
On the COOH-terminal side of the CARD domain, Apaf-1
contains a region of 320 amino acids that is homologous
The Role of Caspase-9
to CED-4. This region contains Walker's A and B boxes
All of our data are consistent with the suggestion that
and the nucleotide p-loop (Walker et al., 1982; Zou et
caspase-9 is the caspase that is directly activated by
al., 1997), suggesting that it serves as a nucleotide bind-
Apaf-1 and cytochrome c, at least in the cellular extracts
ing site. Mutations of residues in CED-4 that are required
that we studied. When the HeLa S-100 extracts were
for nucleotide binding destroy its ability to promote cas-
immunodepleted of caspase-9, they lost the ability to
pase activation (Chinnaiyan et al., 1997; Seshagiri and
activate caspase-3, and activity was restored by addi-
Miller, 1997). Similar mutations of Apaf-1 also obliterate
tion of purified caspase-9. The initial cleavage of cas-
its activity (S. M. S. and E. S. A., unpublished data).
pase-9, whether it is through autocatalysis or another
ATP will replace dATP, but the required concentration mechanism, is currently under investigation.
is much higher (1 mM for dATP versus 1 mM for ATP) Several other caspases, including caspase-1, -2, -8,
(Figure 5). The intracellular concentrations of ATP and and -10, also contain long NH2-terminal CARDs like thatdATP are in the range of 0.2±10 mM and 10±20 mM, of caspase-9 (Thornberry et al., 1992; Wang et al., 1994;
respectively (Skoog and Bjursell, 1974), raising the pos- Boldin et al., 1996; Muzio et al., 1996; Srinivasula et al.,
sibility that ATP, as well as dATP, maysupport apoptosis 1996b). It is possible that one or more of these caspases
within the cell. Our observation that nonhydrolyzable might substitute for caspase-9 in tissues in which their
analogs of ATP fail to subsitute for ATP suggests that expression is high.
hydrolysis of the high-energy bond is required for cas-
pase activation. Experimental Procedures
The suggestion that ATP is required to carry out the
General Methods and Materialscell suicide program is supported by recent observation
We obtained dATP and other nucleotides from Pharmacia, radioac-that cells depleted of ATP undergo necrosis instead of
tive materials from Amersham, and molecular weight standards forapoptosis in response to apoptotic stimuli (Eguchi et
SDS-PAGE and gel filtration chromatography from Bio-Rad and
al., 1997; Leist et al., 1997). Restoring ATP levels re- GIBCO-BRL. Protein concentrations were determined by the Brad-
stored the apoptotic response (Eguchi et al., 1997; Leist ford method; general molecular biology methods were used as de-
scribed in Sambrook et al. (1989).et al., 1997).
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Figure 9. Model of Caspase-3 Activation
See the text for details. Mitochondria, Apaf-1,
cytochrome c, caspase-9, and caspase-3 are
indicated.
Assay for Caspase-3 Activation with buffer A. The column was washed with 20 ml of buffer A con-
taining 100 mM NaCl and eluted with a 50 ml linear gradient fromCaspase-3 was translated and purified as described (Liu et al.,
1996a). A 3 ml aliquot of the in vitro±translated caspase-3 was incu- 100±300 mM NaCl, both in buffer A. Fractions of 4 ml were collected
and assayed for Apaf-3 activity. The active fractions (12 ml, 3.4 mgbated with the indicated protein fraction in the presence of 1 mM
dATP and 1 mM of additional MgCl2 at 308C for 1 hr in a final volume of protein) were pooled and loaded directly onto a Superdex 200
16/60 gel-filtration column equilibrated with buffer A containing 100of 20 ml of buffer A (20 mM HEPES-KOH [pH 7.5], 10 mM KCl,
1.5 mM MgCl2, 1 mM sodium EDTA, 1 mM sodium EGTA, 1 mM mM NaCl. The column was eluted with the same buffer (6 runs), and
fractions of 4 ml were collected starting from 30 ml of elution. Thedithiothreitol, and 0.1 mM PMSF). At the end of the incubation, 7 ml
of 43 SDS sample buffer was added to each reaction. After boiling fractions were assayed for Apaf-3 activity and the active fractions
were pooled (48 ml, 480 mg of protein). After diluting with equalfor 3 min, each sample was subjected to a 15% SDS-PAGE. The
gel was transferred to a nitrocellulose filter, which was subsequently volume of buffer A, the sample was loaded directly onto a Mono Q
5/5 column (Pharmacia) equilibrated with buffer A containing 50 mMexposed to a phosphorimaging plate and visualized in a Fuji BAS-
1000 Phosphorimager. NaCl. The column was eluted with a 20 ml linear gradient from
50±250 mM NaCl, both in buffer A. Fractions of 1 ml were collected
and assayed for Apaf-3 activity. A 0.5 ml aliquot of the peak Apaf-3Purification of Apaf-3 from HeLa S-100
All purification steps were carried out at 48C. All chromatography fraction (12 mg) from the Mono Q column was directly loaded onto
a 5 ml 10%±30% linear glycerol gradient in buffer A. After centrifuga-steps except the SP-Sepharose column (Pharmacia), hydroxylapa-
tite column (Bio-Rad), and Q-Sepharose (Pharmacia) were carried tion at 55,000 rmp for 16 hr in a SW 60 rotor (Beckman), fractions
of 0.5 ml were collected from bottom to top and assayed for Apaf-3out using an automatic fast protein liquid chromatography (FPLC)
station (Pharmacia). activity.
HeLa S-100 (700 ml [4.9g of protein]) from 100 liters of suspension-
cultured HeLa cells was prepared as described in Liu et al. (1996b) Production of Caspase-9 Fusion Protein
The full-length caspase-9 coding region (Srinivasula et al., 1996a)and applied to a SP-Sepharose column (200 ml bed vol) equilibrated
with buffer A. The 800 ml flow-through fraction (3648 mg of protein) was cloned into the BamHI site of pET-15b vector (Novagen). The
expression plasmid was transformed into bacteria BL21 cells (Nova-was collected and loaded directly onto a hydroxylapaptite column
(50 ml bed vol) equilibrated with buffer A. Flow-through fraction gen). In a typical caspase-9 preparation, a 5 ml overnight culture of
bacteria containing the caspase-9 expression vector was added(2741 mg of protein) of the hydroxylapatite column was directly
loaded on to a Q-Sepharose column (100 ml bed vol). The column into a 1 liter LB broth, cultured for 3 hr by shaking at 220 rpm in
378C. Isopropyl-1-thio-B-D-galactopyranoside (IPTG) was added towas washed with three column vol of buffer A. The bound material
was eluted with three 200 ml steps elution with buffer A containing the culture in a final concentration of 1 mM and continued shaking
for another 2 hr. The bacteria were pelleted by centrifugation, and0.1 M NaCl, 0.2 M NaCl, and 0.3 M NaCl. The fractions from step
elution were assayed for Apaf-3 activity. Ammonium sulfate (1 M) the bacterial pellet was resuspended in 10 vol of buffer A. The
resuspended cells were lysed in buffer A by sonication. After centrif-was added directly to the active faction (0.2 M NaCl elution, 279
mg of protein), and after rotating at 48C for 1 hr, the precipitate was ugation at 10,000 g for 15 min, the supernatant was loaded onto a
nickel affinity column (2 ml). The column was washed with 20 mlpelleted by centrifugation in a SA-600 rotor (Sorvall) at 15,000 rpm
for 20 min, and the supernatant was directly loaded onto a Phenyl- buffer A followed by 20 ml buffer A containing 1 M NaCl. After
reequilibrating the column with 20 ml buffer A, the bound proteinSuperose 10/10 column (Pharmacia) equilibrated with buffer A con-
taining 1 M ammonium sulfate. The column was eluted with a 200 was eluted with buffer A containing 250 mM imidazole. The identity
of caspase-9 was verified by SDS-PAGE followed by Coomassieml linear gradient of buffer A containing 1 M ammonium sulfate to
buffer A. Fractions of 4 ml were collected and assayed for Apaf-3 blue staining and used to immunize rabbits.
The active caspase-9 was generated by transforming bacterialactivity after diluting 1/10 with buffer A. Active fractions (20 ml, 9.8
mg of protein) were pooled and dialyzed against buffer A and then competent cells BL21(DE3) (Novagen) with a full-length caspase-9,
an independent clone that differs from the published sequence atloaded onto a 5 ml heparin-agarose column (Pharmacia) equilibrated
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